What it is
Chonluten is a short peptide bioregulator from the Khavinson literature.
Evidence boundary
Regional literature only. Not a validated respiratory treatment.
Trial evidence
- PMID 35408963 — Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.
Preparation and measurement
Reconstitution: 20 mg vial + 3 mL BAC = 6.67 mg/mL.
Concentration matches.
Reference schedule
| Phase | Dose | Draw / measure | Frequency | Weekly total |
|---|---|---|---|---|
| Cycle | 300 mcg | 4.5 U (0.045 mL) | Daily during cycle | 2.1 mg/week |
Cycle
- Dose
- 300 mcg
- Draw / measure
- 4.5 U (0.045 mL)
- Frequency
- Daily during cycle
- Weekly total
- 2.1 mg/week
Weekly totals apply only during the active phase.
Titration rules
-
Standard cycle: Daily dose during 10–20 day active phase, 5–6 month break.
-
Do not read this as stronger than the evidence supports.
-
Tolerability
-
Injection-site reactions
-
Regional protocol claims only
Practical rules
- Rotate sites if it is being compared in notes.